🇺🇸 FDA
Pipeline program

Sham Injection

Halo-117-401

Approved small_molecule completed

Quick answer

Sham Injection for Type 1 Diabetes Mellitus is a Approved program (small_molecule) at HALOZYME THERAPEUTICS, INC. with 1 ClinicalTrials.gov record(s).

Program details

Company
HALOZYME THERAPEUTICS, INC.
Indication
Type 1 Diabetes Mellitus
Phase
Approved
Modality
small_molecule
Status
completed

Clinical trials